Active	Status	Sponsor type	Region	Phase	Filter
5 Active 2 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Homøe, Preben
NCT06338995: A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)	Recruiting	3	510	Europe, Canada, Japan, US, RoW	LY3650150, Placebo, Standard therapy for INCS	Eli Lilly and Company	Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)	10/26	02/27
NCT06711159: SLEEPINESS - a Search for a Biomarker of Excessive Daytime Sleepiness in Severe Obstructive Sleep Apnoea - An Explorative Study	Recruiting	N/A	15	Europe	continuous positive airway pressure	Zealand University Hospital, UNEEG Medical A/S, T&W Engineering A/S	Obstructive Sleep Apnea (OSA), Excessive Daytime Sleepiness	10/25	12/25
Sarkez-Knudsen, Mathias
NCT06711159: SLEEPINESS - a Search for a Biomarker of Excessive Daytime Sleepiness in Severe Obstructive Sleep Apnoea - An Explorative Study	Recruiting	N/A	15	Europe	continuous positive airway pressure	Zealand University Hospital, UNEEG Medical A/S, T&W Engineering A/S	Obstructive Sleep Apnea (OSA), Excessive Daytime Sleepiness	10/25	12/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Homøe, Preben
NCT06338995: A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)	Recruiting	3	510	Europe, Canada, Japan, US, RoW	LY3650150, Placebo, Standard therapy for INCS	Eli Lilly and Company	Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)	10/26	02/27
NCT06711159: SLEEPINESS - a Search for a Biomarker of Excessive Daytime Sleepiness in Severe Obstructive Sleep Apnoea - An Explorative Study	Recruiting	N/A	15	Europe	continuous positive airway pressure	Zealand University Hospital, UNEEG Medical A/S, T&W Engineering A/S	Obstructive Sleep Apnea (OSA), Excessive Daytime Sleepiness	10/25	12/25
Sarkez-Knudsen, Mathias
NCT06711159: SLEEPINESS - a Search for a Biomarker of Excessive Daytime Sleepiness in Severe Obstructive Sleep Apnoea - An Explorative Study	Recruiting	N/A	15	Europe	continuous positive airway pressure	Zealand University Hospital, UNEEG Medical A/S, T&W Engineering A/S	Obstructive Sleep Apnea (OSA), Excessive Daytime Sleepiness	10/25	12/25